Pieris Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PIRS and other ETFs, options, and stocks.

About PIRS

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. 

CEO
Stephen S. Yoder
CEOStephen S. Yoder
Employees
141
Employees141
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2001
Founded2001
Employees
141
Employees141

PIRS Key Statistics

Market cap
85.57M
Market cap85.57M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
121.50K
Average volume121.50K
High today
$1.19
High today$1.19
Low today
$1.11
Low today$1.11
Open price
$1.16
Open price$1.16
Volume
55.27K
Volume55.27K
52 Week high
$5.30
52 Week high$5.30
52 Week low
$1.10
52 Week low$1.10

PIRS Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 2, Pre-Market
ActualExpected Nov 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.